Chantix is a nicotinic receptor partial agonist indicated for use as an aid to smoking cessation treatment.
Chantix is a prescription medicine to help adults stop smoking. Quitting smoking can lower your chances of having lung disease, heart disease or getting certain types of cancer that are related to smoking. Chantix is not recommended for people under 18 years of age.
Smoking cessation therapies are more likely to succeed for patients who are motivated to stop smoking and who are provided additional advice and support.
You should set a date to stop smoking. Begin Chantix one week before this date. Alternatively, you can begin Chantix and then quit smoking between days 8 and 35 of treatment.
Chantix has not been studied with other treatments for stopping smoking.